Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Hair loss in Saudi Arabia causes a low psychosocial impact, with less effect on those without a family history of hair loss.

A new wearable device stops hair loss and boosts hair growth safely.

Nanocarriers could improve hair loss treatment but need more research for effectiveness and safety.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

Topical dutasteride shows promise for hair loss but needs more research.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Severe and early hair loss may indicate a higher risk of heart disease.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

New dissolving and implantable microneedle patches have been created for a long-lasting, non-invasive delivery of the drug finasteride.

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Alopecia patients have more mast cells in their scalps, especially in severe cases and older age, with alopecia areata showing the highest increase.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Possible link between COVID-19 and hair loss; more research needed.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Androgenetic alopecia significantly harms quality of life, affecting emotions and relationships.

Minoxidil might cause blood vessel-related skin lesions when applied to the scalp.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

Hirsutism and acanthosis nigricans are reliable skin signs of PCOS linked to metabolic issues, while acne is not a reliable marker of the condition.

Women with PCOS often have more hair growth, skin darkening, and acne, which are linked to hormonal and metabolic issues.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

The study found that 7.21% of young girls have polycystic ovarian syndrome, with symptoms like irregular periods, abnormal hair growth, and acne. Early diagnosis is important to prevent long-term complications.

People with Alopecia Areata and Androgenic Alopecia have more mast cells in their scalp than healthy individuals, especially those with Alopecia Areata.

Women with PCOS often have hirsutism and skin changes, which indicate a need for metabolic health checks.

Hirsutism and acanthosis nigricans are reliable skin signs of PCOS and suggest the need for further tests for related health issues.